Zuo, A., Liang, D., Shao, H., Born, W. K., Kaplan, H. J., & Sun, D. (2012). In vivo priming of IL-17(+) uveitogenic T cells is enhanced by Toll ligand receptor (TLR)2 and TLR4 agonists via γδ T cell activation.
Stile di citazione ChicagoZuo, Aijun, Dongchun Liang, Hui Shao, Willi K. Born, Henry J. Kaplan, e Deming Sun. In Vivo Priming of IL-17(+) Uveitogenic T Cells Is Enhanced By Toll Ligand Receptor (TLR)2 and TLR4 Agonists Via γδ T Cell Activation. 2012.
Citazione MLAZuo, Aijun, et al. In Vivo Priming of IL-17(+) Uveitogenic T Cells Is Enhanced By Toll Ligand Receptor (TLR)2 and TLR4 Agonists Via γδ T Cell Activation. 2012.
Attenzione: Queste citazioni potrebbero non essere precise al 100%.